Evidence map›Paper›PMID 36278631›Full record

ReviewJournal of functional biomaterials2022

Li-Doped Bioactive Ceramics: Promising Biomaterials for Tissue Engineering and Regenerative Medicine.

Ahmad Reza Farmani, Mohammad Ali Salmeh, Zahra Golkar, Alaa Moeinzadeh, Farzaneh Farid Ghiasi, Sara Zamani Amirabad, Mohammad Hasan Shoormeij, Forough Mahdavinezhad, Simin Momeni, Fatemeh Moradbeygi and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of functional biomaterials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Effect of TiOScientific reports · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Lithium: A Promising Anticancer Agent.Life (Basel, Switzerland) · 2023
    Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 12 institutions in 3 countries.

Ahmad Reza FarmaniTissue Engineering and Applied Cell Sciences Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran 14166-34793, Iran.ORCID 0000-0003-1149-3843
Mohammad Ali SalmehDepartment of Biotechnology, School of Chemical Engineering, College of Engineering, University of Tehran, Tehran 14155-6619, Iran.
Zahra GolkarDepartment of Midwifery, Firoozabad Branch, Islamic Azad University, Firoozabad 74715-117, Iran.
Alaa MoeinzadehDepartment of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran 14496-14535, Iran.
Farzaneh Farid GhiasiDepartment of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran 14496-14535, Iran.
Sara Zamani AmirabadDepartment of Chemical Engineering, Faculty of Engineering, Yasouj University, Yasouj 75918-74934, Iran.
Mohammad Hasan ShoormeijEmergency Medicine Department, Shariati Hospital, Tehran University of Medical Sciences, Tehran 14166-34793, Iran.
Forough MahdavinezhadAnatomy Department, School of Medicine, Tehran University of Medical Sciences, Tehran 14166-34793, Iran.
Simin MomeniChemistry Department, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz 83151-61355, Iran.
Fatemeh MoradbeygiDepartment of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz 71348-14336, Iran.
Jafar AiTissue Engineering and Applied Cell Sciences Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran 14166-34793, Iran.
John G HardyDepartment of Chemistry, Faraday Building, Lancaster University, Lancaster LA1 4YB, UK.ORCID 0000-0003-0655-2167
Amir MostafaeiDepartment of Mechanical, Materials, and Aerospace Engineering, Illinois Institute of Technology, 10 W 32nd Street, Chicago, IL 60616, USA.
Iran University of Medical Sciences · IRFasa University of Medical Sciences · IRIllinois Institute of Technology · USIslamic Azad University, Tehran · IRLancaster University · GBQazvin University of Medical Sciences · IRShahid Chamran University of Ahvaz · IRShariati Hospital · IRShiraz University of Medical Sciences · IRTehran University of Medical Sciences · IRUniversity of Tehran · IRYasouj University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lithium (Li) is a metal with critical therapeutic properties ranging from the treatment of bipolar depression to antibacterial, anticancer, antiviral and pro-regenerative effects. This element can be incorporated into the structure of various biomaterials through the inclusion of Li chloride/carbonate into polymeric matrices or being doped in bioceramics. The biocompatibility and multifunctionality of Li-doped bioceramics present many opportunities for biomedical researchers and clinicians. Li-doped bioceramics (capable of immunomodulation) have been used extensively for bone and tooth regeneration, and they have great potential for cartilage/nerve regeneration, osteochondral repair, and wound healing. The synergistic effect of Li in combination with other anticancer drugs as well as the anticancer properties of Li underline the rationale that bioceramics doped with Li may be impactful in cancer treatments. The role of Li in autophagy may explain its impact in regenerative, antiviral, and anticancer research. The combination of Li-doped bioceramics with polymers can provide new biomaterials with suitable flexibility, especially as bio-ink used in 3D printing for clinical applications of tissue engineering. Such Li-doped biomaterials have significant clinical potential in the foreseeable future.

Indexed as

autophagybioactive biomaterialsbioceramicscancer treatmentdrug deliverylithiumtissue engineering

Identifiers

PMID36278631
PMCPMC9589997
OpenAlexW4297201305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.